Cargando…
Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy
Ductal carcinoma in situ (DCIS) often upgrade to invasive breast cancer at surgery. The current study aimed to identify factors associated with pathological underestimation and evaluate concordance rates of biomarkers between biopsy and surgery. Patients diagnosed with DCIS at needle biopsy from 200...
Autores principales: | Zhou, Hemei, Yu, Jing, Wang, Xiaodong, Shen, Kunwei, Ye, Jiandong, Chen, Xiaosong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828849/ https://www.ncbi.nlm.nih.gov/pubmed/35140303 http://dx.doi.org/10.1038/s41598-022-06206-7 |
Ejemplares similares
-
Ductal carcinoma in situ diagnosed using an ultrasound-guided 14-gauge core needle biopsy of breast masses: can underestimation be predicted preoperatively?
por: Park, Sung Hee, et al.
Publicado: (2014) -
Predicting Underestimation of Invasive Cancer in Patients with Core-Needle-Biopsy-Diagnosed Ductal Carcinoma In Situ Using Deep Learning Algorithms
por: Do, Luu-Ngoc, et al.
Publicado: (2022) -
Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
por: Si, Jing, et al.
Publicado: (2019) -
Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
por: Si, Jing, et al.
Publicado: (2019) -
Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy
por: Lee, Kwan Ho, et al.
Publicado: (2019)